ישראל - עברית - Ministry of Health

rafa laboratories ltd - dry extract from cimicifugae rhizoma (black cohosh) - טבליה - dry extract from cimicifugae rhizoma (black cohosh) 6.5 mg - cimicifugae rhizoma

ישראל - עברית - Ministry of Health

rafa laboratories ltd - dry extract from cimicifugae rhizoma (black cohosh) - טבליה - dry extract from cimicifugae rhizoma (black cohosh) 13 mg - cimicifugae rhizoma

ישראל - עברית - Ministry of Health

dr.samuelov importing & marketing ltd - dry extract from cimicifuga racemosa (l.) nutt, rhizoma (black cohosh) (5-10:1) extraction solvent: ethanol 58% (v/v) - טבליות מצופות פילם - dry extract from cimicifuga racemosa (l.) nutt, rhizoma (black cohosh) (5-10:1) extraction solvent: ethanol 58% (v/v) 2.8 mg - cimicifugae rhizoma

ישראל - עברית - Ministry of Health

pharma shalom - melissa officinalis; valerian dry extract - טבליות מצופות - valerian dry extract 120 mg; melissa officinalis 80 mg - other hypnotics and sedatives - sedative in states of tension, nervousness and insomnia.

ישראל - עברית - Ministry of Health

pharma shalom - melissa officinalis; valerian dry extract - טבליות מצופות - valerian dry extract 120 mg; melissa officinalis 80 mg

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 7.5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva is indicated for the management of the manifestations of psychotic disorders. olanzapine teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanzapine teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 5 mg - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.